Neko Health, the Stockholm-based HealthTech company, just announced a $700 million Series C led by Lightspeed Venture Partners. The company plans to open its first US clinics in New York and other cities this year, bringing proactive healthcare to America.
Neko Health, the Stockholm-based HealthTech company, just announced a massive $700 million Series C funding round. The company is gearing up to open its first US clinics in New York and other cities later this year.
This round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. Existing investors like Atomico, General Catalyst, and Lakestar also chipped in, alongside new backers including Liberty City Ventures, Positive Sum, and BDT & MSD. As part of the deal, David Ofer from O.G. Venture Partners will join the board. This follows a $285 million Series B in January 2025.
### Who's Betting on Neko Health?
The investor list reads like a who's who of tech and entertainment. You've got Maria Sharapova, Mark Zuckerberg and Priscilla Chan, Thierry Henry, Ari Emanuel, Claudia Schiffer and Sir Matthew Vaughn, Danny Meyer, Jimmy Iovine, Tim Ferriss, and will.i.am. They join existing backers like Alexis Ohanian from Seven Seven Six, Alex Tew and Michael Acton-Smith from Calm, Gary Vaynerchuk, Jessie Inchauspé, Katie Haun, Raj Shamani, Steven Bartlett, Zoë Saldaña, and Marco Perego-Saldaña.
### What's the Big Idea?
Hjalmar Nilsonne, co-founder and CEO, said, "This funding is a strong vote of confidence in what we set out to do when we opened our first clinic three years ago: a completely new healthcare experience designed to keep people healthy, catch problems early and help prevent disease before it even starts."
He added, "With this round, we're taking that mission to the US for the first time, while continuing to invest in the research and technology that make prevention possible at scale."
Founded in 2023 by Nilsonne and Daniel Ek (the Spotify CEO), Neko Health aims to flip the script on healthcare. Instead of waiting for you to get sick, they want to catch issues early. Their model combines proprietary tech, clinical research, and in-person analysis from clinicians.
### The Core Product: Neko Health Scan
Their main offering is the Neko Health Scan, a 60-minute, non-invasive health assessment that captures millions of data points. It's priced at $380 in the UK and about $260 in Sweden. The scan uses sensors and blood analysis to check skin health, pre-diabetes risk, blood abnormalities, and risk factors for metabolic syndrome, stroke, and heart attack. Results come back within minutes, and you discuss them with a doctor right there.
### Recent Upgrades
Just three weeks ago, Neko rolled out its biggest scan upgrade yet. It now captures body composition in seconds, and clinicians can review your wearable data across all clinics. This is possible because Neko builds everything in-house—hardware, software, and the consumer experience.
Last month, they opened a new Stockholm clinic featuring their latest devices: Derma-2, Echo-2, and Spectrum-2. These upgraded gadgets capture more detailed health signals from skin, heart, and circulation. They'll roll out to all clinics in the coming months.
### What This Means for US Expansion
Bejul Somaia from Lightspeed Venture Partners noted, "Over the past eighteen months, Neko Health has demonstrated remarkable innovation and growth, attacking one of the largest markets." With $700 million in the bank, Neko is ready to bring its proactive healthcare model to Americans. If you're tired of reactive medicine, this could be a game-changer.